GO
Loading...

Market Outlook

More

  • Amazon adds HBO: Blow to Netflix?     Wednesday, 23 Apr 2014 | 11:37 AM ET

    Discussing what the deal between Amazon and HBO means to Netflix, with Michael Pachter, Wedbush Securities managing director of equity research.

  • European markets close: Record euro zone debt     Wednesday, 23 Apr 2014 | 11:30 AM ET

    CNBC's Simon Hobbs reports on all the market moving events in Europe today, including business activity nearing a 3-year high and euro zone debt hitting a record of 92.6% of GDP.

  • Tech bubble 2000 vs. today     Wednesday, 23 Apr 2014 | 11:16 AM ET

    CNBC's Dominic Chu looks back at tech valuations at the peak of the Internet bubble 15 years ago and compares them to valuations today.

  • Too simple to say it's a bubble: Pro     Wednesday, 23 Apr 2014 | 11:01 AM ET

    Jon Steinberg, BuzzFeed president & COO, discusses investor David Einhorn's comments that we are witnessing our second tech bubble in 15 years.

  • Santelli Exchange: Revamping tax code     Wednesday, 23 Apr 2014 | 10:47 AM ET

    CNBC's Rick Santelli and Ed Lazear, former Council of Economic Advisors chairman, discuss the tax code system and the health of the U.S. economy.

  • John Sculley: Time for Cook's first creative leap     Wednesday, 23 Apr 2014 | 10:17 AM ET

    Former Apple CEO John Sculley, discusses Apple innovation and if the DNA of Apple has changed under CEO Tim Cook. Sculley also weighs in on earnings expectations for the tech giant.

  • YUM will grind higher: Analyst     Wednesday, 23 Apr 2014 | 10:09 AM ET

    David Palmer, RBC Capital Markets managing director, breaks down Yum! Brands' Q1 earnings that missed on their top line and discusses the company's China business.

  • Tech & biotech plays for your portfolio     Wednesday, 23 Apr 2014 | 10:04 AM ET

    Kevin Caron, Stifel Private Client Group market strategist, and Doug MacKay, Broadleaf Partners president & CIO, discuss signs of a tech bubble and share their investment strategies on hot technology stocks.

  • Morning market roundup     Wednesday, 23 Apr 2014 | 9:41 AM ET

    CNBC's Mary Thompson looks at what's moving in early morning trading, including activity in P&G, Boeing and AT&T, as the Dow Transports nears all-time highs.

  • Cramer: Qualcomm trade is tricky     Wednesday, 23 Apr 2014 | 9:30 AM ET

    Don't trade Qualcomm off the earnings announcement, says CNBC's Jim Cramer.

  • Cramer: Gilead crux of health care in US     Wednesday, 23 Apr 2014 | 9:08 AM ET

    Record sales of a new hepatitis C drug pushed the first-quarter earnings of Gilead Sciences beyond expectations. The "Squawk on the Street" news team break down its quarterly beat.

  • Cramer: It wasn't front running     Wednesday, 23 Apr 2014 | 8:45 AM ET

    CNBC's Jim Cramer shares his thoughts on the legality of Bill Ackman's deal with Valeant to acquire Allergan, and why the SEC has an "existential crisis."

  • What burst of M&A activity says about the market Wednesday, 23 Apr 2014 | 6:31 AM ET
    Traders work on the floor of the New York Stock Exchange, April 16, 2014.

    The bull market is seeing the equivalent of its first gray hairs and the proof is in Tuesday's blast of merger activity.

  • Paul Raines, GameStop CEO, discusses how its leadership in digital sales, market share, and ability to drive loyalty with rewards propels consumers to stay with the gaming store.

  • Leadership in today's market: Cramer     Tuesday, 22 Apr 2014 | 6:00 PM ET

    Mad Money host Jim Cramer breaks down the momentum many sectors saw in today's rally.

  • Xbox battles for your living room     Tuesday, 22 Apr 2014 | 5:48 PM ET

    Discussing Xbox series "Every Street United" and pricing competition for original content, with Jonathan Weinbach, Mandalay Sports Media executive producer and senior vice president.

  • Biogen Idec has room to run: Pro     Tuesday, 22 Apr 2014 | 5:40 PM ET

    Mark Newton, Greywolf Execution Partners, looks at biotech's rebound and stabilization in the space.

  • ValueAct passes Valeant torch to Pershing     Tuesday, 22 Apr 2014 | 5:30 PM ET

    CNBC's David Faber reports the latest on Valeant and Pershing Square's efforts to acquire Allergan.

  • Bove: Citi poorly managed     Tuesday, 22 Apr 2014 | 5:18 PM ET

    Discussing the fundamental concern of management for Citigroup, with Richard Bove, Rafferty Capital.

  • Yum Brands beats on bottom line     Tuesday, 22 Apr 2014 | 5:15 PM ET

    Yum Brands is reporting Q1 EPS of $0.87 ex-items on revenues of $2.72 billion, with CNBC's Sara Eisen.

Most Popular Video

Thursday, 24 Apr 2014 | 1:05 AM ET

Jerry Braakman, chief investment officer at First American Trust, says Apple and Facebook reported "great" results and owning technology stocks is still attractive.

Thursday, 24 Apr 2014 | 12:16 AM ET

Manpreet Gill, Senior Investment Strategist at Standard Chartered Bank, attributes the decline of Japanese shares to the lack of a TPP agreement during U.S. President Barack Obama's visit to Tokyo.

Wednesday, 23 Apr 2014 | 3:00 PM ET

CNBC's Becky Quick discusses Warren Buffett's feelings about Coke, IBM and his general sentiment about the market.